Star Lake Bioscience Co., Inc. Zhaoqing Guangdong (600866.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 4.08

From 52W high−47.97%

Volume20.05M

Market capCNY 7.03B

P/E (TTM)7.2x

P/S (TTM)0.4x

Div yield9.29%

Key dataSep 18, 2026

Open

CNY 4.08

From 52W high

−47.97%

Volume

20.05M

Market cap

CNY 7.03B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

5.6x

P/E (TTM)

7.2x

RSI (14)

37.6

MomentumView details →

1D Return

−0.47%

YTD Return

−41.15%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

7.2x

EV/EBITDA

5.6x

EV/Sales

0.7x

P/S (TTM)

0.4x

P/B (TTM)

0.9x

ProfitabilityView details →

Gross Margin

12.86%

Net Margin

2.93%

EBITDA Margin

13.13%

ROE (TTM)

5.60%

ROA (TTM)

2.63%

Asset Turnover

0.90x

GrowthView details →

Revenue YoY

−9.16%

EPS YoY

−60.73%

FCF YoY

—

Revenue CAGR 3Y

−3.12%

EPS CAGR 3Y

+4.78%

EBITDA YoY

—

MomentumView details →

1D Return

−0.47%

YTD Return

−41.15%

1Y Return

−45.17%

RSI (14)

37.6

vs 50D SMA

−8.75%

vs 200D SMA

−31.59%

Capital & dividendView details →

Debt/Equity

0.67x

Current Ratio

0.97x

Quick Ratio

0.49x

Div Yield

9.29%

Div Rate

CNY 0.38

Div Growth 1Y

+0.00%

EarningsView details →

EPS (Actual)

CNY 0.07

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.00

Avg Surprise (4Q)

—

Rev Surprise

−0.96%

Financials snapshotView financials →

Revenue (TTM)

15.60B

Net Income (TTM)

457.83M

Op. CF (TTM)

151.96M

Latest newsMore news →

Ningxia Yipin Investment Group and its concert party Tie Xiaorong reduced their combined stake in Star Lake Bioscience from 6.71% to 5.81% by selling 15 million shares via block trades between September 9 and September 14, 2026.5d ago

Star Lake Bioscience held its 2026 interim results briefing on September 10, 2026, where it discussed the amino acid and MSG industries being in a capacity-expansion adjustment cycle with the industry at the bottom of the cycle.10d ago

Similar companies

诺禾致源688315.SH Lepu Biopharma Co., Ltd.02157.HK Belite Bio, IncBLTE Alkermes plcALKS XD昊海生688366.SH Arcellx, Inc.ACLX Find similar companies →

Latest newsMore news →

Ningxia Yipin Investment Group and its concert party Tie Xiaorong reduced their combined stake in Star Lake Bioscience from 6.71% to 5.81% by selling 15 million shares via block trades between September 9 and September 14, 2026.5d ago Star Lake Bioscience held its 2026 interim results briefing on September 10, 2026, where it discussed the amino acid and MSG industries being in a capacity-expansion adjustment cycle with the industry at the bottom of the cycle.10d ago